Sex-Specific Outcomes of LBBAP Versus Biventricular Pacing: Results From I-CLAS
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu multicentrická studie, časopisecké články
Grantová podpora
CS/15/3/31405
British Heart Foundation - United Kingdom
Odkazy
PubMed
37737782
DOI
10.1016/j.jacep.2023.08.026
PII: S2405-500X(23)00678-3
Knihovny.cz E-zdroje
- Klíčová slova
- biventricular pacing, cardiac resynchronization therapy, heart failure, left bundle branch area pacing, sex difference,
- MeSH
- blokáda Tawarova raménka MeSH
- kardiomyopatie * terapie MeSH
- lidé MeSH
- srdeční resynchronizační terapie * metody MeSH
- srdeční selhání * MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
BACKGROUND: Cardiac resynchronization therapy (CRT) using biventricular pacing (BVP) has been associated with greater clinical improvement in women than men. Recently, left bundle branch area pacing (LBBAP) has been shown to be an alternative form of CRT. OBJECTIVES: The purpose of this study was to investigate sex-specific outcomes for death and heart failure events in a large, international, multicenter, cohort of patients undergoing CRT with BVP or LBBAP. METHODS: In this international study of 1,778 patients (575 female and 1203 male), sex-specific survival analysis was performed to compare the effect of LBBAP-CRT relative to BVP-CRT on the combined endpoint of death or heart failure hospitalization (HFH), and secondary endpoints of HFH only, and death alone. RESULTS: Female patients were more likely to have nonischemic cardiomyopathy and left bundle branch block (LBBB) and less likely to have hypertension, diabetes, or coronary artery disease than were male patients. Overall, female patients had a better result with LBBAP compared with BVP than did male patients, with a significant 36% reduction in death or HFH (HR: 0.64; 95% CI: 0.43 to 0.97; P = 0.03) and a significant 60% reduction in HFH alone (HR: 0.4; 95% CI: 0.24 to 0.69, P < 0.01). Women had a greater reduction in death or HFH among those with nonischemic cardiomyopathy (HR: 0.45 95% CI: 0.26 to 0.79; P < 0.01) and LBBB (HR: 0.49; 95% CI: 0.27 to 0.87; P < 0.01). Sex-specific echocardiographic outcomes were better in women than in men. CONCLUSIONS: Women obtained significantly greater reductions in the combined endpoint of death or HFH (primarily driven by reduction in HFH) with LBBAP compared with BVP among patients requiring CRT than did men.
Baylor College of Medicine and Texas Heart Institute Houston Texas USA
Geisinger Heart Institute Wilkes Barre Pennsylvania USA
Hospital Universitario Virgen de las Nieves Granada Spain
National Heart and Lung Institute Imperial College London London United Kingdom
Rush University Medical Center Chicago Illinois USA
Santa Maria Della Misericordia Hospital Rovigo Italy
University of Ottawa Heart Institute Ottawa Ontario Canada
University of South Florida Morsani College of Medicine Tampa Florida USA
Velammal Medical College Hospital and Research Institute Madurai India
Virginia Commonwealth University Medical Center Richmond Virginia USA